Motivated by the need for more effective and safer drugs to treat IPF, we aimed to investigate the therapeutic potential of Serpinh1-targeting siRNA in lung slices prepared from murine tissue. The gene discussed is SERPINH1; the disease is idiopathic pulmonary fibrosis.